STOCK TITAN

Calithera Biosciences Stock Price, News & Analysis

CALA OTC Link

Company Description

Calithera Biosciences (OTC Link: CALA) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $24.4K.

CALA stock has gained 0.0% over the past year. Shares last traded at $0.0001.

On a trailing twelve-month basis, Calithera Biosciences reported net income of -$39.6M and diluted earnings per share of $-7.94.

This page provides a comprehensive overview of CALA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$—
0.00%
0.00
Last updated:
-
Performance 1 year
$24.4K

Calithera Biosciences (CALA) stock last traded at $0.0001. At a market capitalization of $24.4K, CALA is classified as a micro-cap stock with approximately 4.9M shares outstanding.

SEC Filings

No SEC filings available for CALA.

Financial Highlights

operating income reached -$42.1M, and net income was -$39.6M. Diluted earnings per share stood at $-7.94. The company generated -$43.6M in operating cash flow. With a current ratio of 3.60, the balance sheet reflects a strong liquidity position.

-$39.6M
Net Income (TTM)
-$43.6M
Operating Cash Flow
Revenue (TTM)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in Calithera Biosciences (CALA) currently stands at 6.8 thousand shares, representing 0.1% of the float. Over the past 12 months, short interest has decreased by 65.1%. This relatively low short interest suggests limited bearish sentiment. With 29.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Calithera Biosciences (CALA) currently stands at 29.1 days, down 26.6% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 339.1% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 303.3 days.

CALA Company Profile & Sector Positioning

Calithera Biosciences (CALA) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.

Investors comparing CALA often look at related companies in the same sector, including Zhejiang Dashang Media (TKVR), Better For You Wellness Inc (BFYW), DRAZCANNA INC (DZCA), Methes Energies (MEIL), and Monkey Rock Group Inc (MKRO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CALA's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Calithera Biosciences (CALA)?

The current stock price of Calithera Biosciences (CALA) is $0.0001 as of March 30, 2026.

What is the market cap of Calithera Biosciences (CALA)?

The market cap of Calithera Biosciences (CALA) is approximately 24.4K. Learn more about what market capitalization means .

What is the net income of Calithera Biosciences (CALA)?

The trailing twelve months (TTM) net income of Calithera Biosciences (CALA) is -$39.6M.

What is the earnings per share (EPS) of Calithera Biosciences (CALA)?

The diluted earnings per share (EPS) of Calithera Biosciences (CALA) is $-7.94 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Calithera Biosciences (CALA)?

The operating cash flow of Calithera Biosciences (CALA) is -$43.6M. Learn about cash flow.

What is the current ratio of Calithera Biosciences (CALA)?

The current ratio of Calithera Biosciences (CALA) is 3.60, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Calithera Biosciences (CALA)?

The operating income of Calithera Biosciences (CALA) is -$42.1M. Learn about operating income.